 |
|
|
 |
|
Rationale:
- Neurologic signs and symptoms attributable to CO toxicity require oxygen therapy to increase the rate of release of CO from
hemoglobin and enhance its elimination via exhalation.
- Acute cardiac signs and symptoms attributable to CO toxicity require oxygen therapy and close monitoring in an inpatient setting.
|
|
Evidence:
- A survey of 176 HBOT facilities showed that most practitioners would hospitalize and treat patients with loss of consciousness,
HbCO greater than 25%, cardiac dysfunction, or any neurologic dysfunction except nausea (41).
|
|
Comments:
|
| FAQs |
|
|
|
Jeffrey T. Chapman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|